Soliqua 100/33 Injection, Solution
Product Images NDC 0024-5761

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Soliqua 100/33 (NDC 0024-5761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Soliqua 01)

FDA Label Image

Chemical Structure (Soliqua 02)

Chemical Structure (Soliqua 02)
This is a list of body parts including upper arms, stomach and thighs. It does not provide any further context or information.*
FDA Label Image

Image (Soliqua 03)

Image (Soliqua 03)
The text describes the design of a medication injection device. It includes a dose selector, rubber seal, medicine scale, medicine name, injection button, and a note that the plunger will not be visible until a few doses have been administered. The text also mentions the expiration date being located on the back.*
FDA Label Image

Image (Soliqua 04)

FDA Label Image

Image (Soliqua 05)

FDA Label Image

Image (Soliqua 06)

FDA Label Image

Image (Soliqua 07)

FDA Label Image

Image (Soliqua 08)

FDA Label Image

Image (Soliqua 09)

FDA Label Image

Image (Soliqua 10)

FDA Label Image

Image (Soliqua 11)

FDA Label Image

Image (Soliqua 12)

FDA Label Image

Image (Soliqua 13)

FDA Label Image

Image (Soliqua 14)

FDA Label Image

Image (Soliqua 15)

FDA Label Image

Image (Soliqua 16)

FDA Label Image

Image (Soliqua 17)

FDA Label Image

Image (Soliqua 18)

FDA Label Image

Image (Soliqua 19)

FDA Label Image

Image (Soliqua 20)

FDA Label Image

Image (Soliqua 21)

FDA Label Image

Image (Soliqua 22)

FDA Label Image

Image (Soliqua 23)

FDA Label Image

Image (Soliqua 24)

FDA Label Image

Image (Soliqua 25)

Image (Soliqua 25)
SOLIQUA® 100/33 is a prescription injection medication consisting of 100 units/mL insulin glargine and 33 mcg/mL lixisenatide. It is intended solely for subcutaneous injections and for single patient use only. SOLIQUA® 100/33 should be refrigerated at 36°F to 46°F (2C to 8°C) prior to first use, and protected from light. After first use, the pen should be stored at room temperature up to 77°F (25°C) for 28 days before disposal. A medication guide and secure sticker should be included by the supplier. Needles sold by separate manufacturers are compatible. Dosage adjustments should be made cautiously under medical supervision, and its use is not recommended for pregnant or nursing women without appropriate professional advice. Keep out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.